Pharmaceutical manufacturer for Mannitol in United States of America

Pfanstiehl is globally recognized as a leader in manufacturing cGMP high-purity, low-endotoxin, low-metal injectable-grade excipients and biopharmaceutical components for various applications in bioprocessing, formulation, and specialty areas. Additionally, Pfanstiehl operates as a prominent contract development and manufacturing organization (CDMO), specializing in the isolation, purification, custom synthesis, and scale-up development of small molecule Active Pharmaceutical Ingredients (APIs) ranging from gram to multi-ton commercial quantities. While many ingredient manufacturers or resellers cater to various industries like food, cosmetics, agriculture, and nutritional supplements, providing only a limited range of “pharma-grade” ingredients, Pfanstiehl’s exclusive focus lies in Biopharma applications, demonstrating a dedicated commitment to this specific sector

ROQUETTE is dedicated to providing the finest from natural sources. It stands as a worldwide frontrunner in plant-derived components, an innovator in plant-derived proteins, and a top supplier of medical excipients. By working alongside its clients and associates, the organization tackles present and future societal obstacles by harnessing the capabilities of nature to present superior ingredients for the food, nutrition, and health sectors. These components satisfy distinct and vital requirements, promote healthier ways of living, and are essential elements of life-preserving medications.

Rochem International, Inc. has been a prominent distributor of pharmaceutical, food, nutritional, and animal health ingredients since its establishment in 1994. It procures top-notch ingredients produced in China. With its headquarters in Hauppauge, New York, Rochem operates 16 global offices to meet its clients' requirements. The company's activities adhere to cGMP standards and have undergone audits by the USFDA and various multinational entities. Furthermore, it provides training and conducts audits for its partners to ensure FDA compliance for their technologies and systems.

Ingredion Incorporated (NYSE: INGR) operates as a global provider of innovative ingredient solutions. In the Pharma and Nutraceuticals sectors, we collaborate with formulators in search of functional materials to improve formulation performance and address technical obstacles. Our Pharma Solutions Portfolio comprises of binders, fillers, superdisintegrants, lubricants, gelatine replacers for softgel, viscosifiers, encapsulation emulsions, and parenteral APIs. Aligned with current and emerging trends and regulations, we are continuously evolving to integrate cGMP facilities, regulatory support, global presence, and collaborative technical assistance to serve as Your Problem-Solving Partner.